MX9704693A - Sales de acido clavulanico. - Google Patents
Sales de acido clavulanico.Info
- Publication number
- MX9704693A MX9704693A MX9704693A MX9704693A MX9704693A MX 9704693 A MX9704693 A MX 9704693A MX 9704693 A MX9704693 A MX 9704693A MX 9704693 A MX9704693 A MX 9704693A MX 9704693 A MX9704693 A MX 9704693A
- Authority
- MX
- Mexico
- Prior art keywords
- salt
- clavulanic acid
- optionally
- inert substituents
- ether
- Prior art date
Links
- HZZVJAQRINQKSD-PBFISZAISA-N clavulanic acid Chemical class OC(=O)[C@H]1C(=C/CO)/O[C@@H]2CC(=O)N21 HZZVJAQRINQKSD-PBFISZAISA-N 0.000 title abstract 4
- 150000003839 salts Chemical class 0.000 abstract 3
- 125000001424 substituent group Chemical group 0.000 abstract 3
- HZZVJAQRINQKSD-UHFFFAOYSA-N Clavulanic acid Natural products OC(=O)C1C(=CCO)OC2CC(=O)N21 HZZVJAQRINQKSD-UHFFFAOYSA-N 0.000 abstract 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract 2
- 229960003324 clavulanic acid Drugs 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 239000003782 beta lactam antibiotic agent Substances 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- SBOJXQVPLKSXOG-UHFFFAOYSA-N o-amino-hydroxylamine Chemical compound NON SBOJXQVPLKSXOG-UHFFFAOYSA-N 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 abstract 1
- 239000002132 β-lactam antibiotic Substances 0.000 abstract 1
- 229940124586 β-lactam antibiotics Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Cephalosporin Compounds (AREA)
Abstract
Una sal de di-clavulanato derivada de ácido clavulánico y un etér diamino de la formula (I), donde R1 es un grupo alquileno, que tiene opcionalmente uno o más sustituyentes inertes; y cada uno de R2 y R3 es un átomo de hidrogeno o un grupo alquilo, que tienen opcionalmente uno o más sustituyentes inertes, o R2 y R3 juntos completan un anillo hetrocíclico que tiene 4 a 7 átomos de carbono, teniendo de nuevo opcionalmente uno o más sustituyentes inertes. La sal se prepara al hacer reaccionar un éter bis(2-dialquilaminoalquileno) (o una sal del mismo) con ácido clavulánico en un solvente orgánico y aislar la sal resultante. La sal de ácido clavulánico puede utilizarse en formulaciones farmacéuticas junto con un vehículo farmacéuticamente aceptable, y opcionalmente un antibiotico beta-lactamo, y se utiliza como un intermediario para la sal de potasio.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9426261.5 | 1994-12-24 | ||
| GBGB9426261.5A GB9426261D0 (en) | 1994-12-24 | 1994-12-24 | Clavulanic acid salts |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX9704693A true MX9704693A (es) | 1998-06-30 |
| MXPA97004693A MXPA97004693A (es) | 1998-10-30 |
Family
ID=
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8400422A1 (es) | "procedimiento de preparacion de eteres triciclicos, asi como de sus sales de adicion con un acido mineral u organico terapeuticamente compatible". | |
| CA2228044A1 (en) | Dibenzimidazole radioprotectors | |
| IL103944A (en) | Piperazine derivatives, their preparation and pharmaceutical compositions containing them | |
| ES8500948A1 (es) | Un procedimiento para la preparacion de derivados de acilmorrfinano. | |
| ES8307760A1 (es) | Un procedimiento para la preparacion de derivados de 4-anilino-pirimidina. | |
| ES8305764A1 (es) | Un procedimiento para la preparacion de derivados carbapenen-2-tio-sustituidos. | |
| NZ232283A (en) | Substituted imidazo(1,2-b)pyridazine derivatives; pharmaceutical compositions and preparatory processes | |
| MY117092A (en) | Chemotherapeutic pyrrolocarbazole derivatives | |
| AU8824391A (en) | New guanidine compounds, process for preparing these and pharmaceutical compositions containing them | |
| ES8800142A1 (es) | Un procedimiento para preparar un derivado de semicarbazida | |
| ES8703869A1 (es) | Procedimiento para preparar compuestos de 5-alaquil-1-fenil-2-piperazinoalquilpirazolin-3-ona. | |
| CA2208520A1 (en) | Diclavulanate salt with a diamino ether and process of preparation | |
| TW238304B (en) | A process for the preparation of 1-substituted-5(4H)-tetrazolinones | |
| SE9703056D0 (sv) | Klavulansyrasalter, förfarande för framställning därav och farmaceutiska kompositioner innehållande dem | |
| ES8101589A1 (es) | Un procedimiento para la preparacion de nuevos compuestos iminicos heterociclicos. | |
| ATE148128T1 (de) | Anthracyclinglycosid-derivate und verfahren zu ihrer herstellung | |
| ATE42295T1 (de) | Penem-derivate, verfahren zu deren herstellung, ihre verwendung und pharmazeutische zusammensetzungen. | |
| CA2053705A1 (en) | Piperazine derivatives | |
| ES8100304A1 (es) | Un procedimiento para preparar derivados de indol policiclicos | |
| ES475596A1 (es) | Procedimiento para la preparacion de derivados de fenoxial- canolaminas | |
| ES8801652A1 (es) | Un procedimiento para la preparacion de un derivado de tiazolidina. | |
| AU624724B2 (en) | Pyrrolo(2,1-b)thiazole derivatives | |
| JO1896B1 (en) | Acid salts such as fulanic | |
| ES471702A1 (es) | Procedimiento para la preparacion de derivados de amida de acido | |
| IL103508A (en) | Pyrazino £1, 2-a| pyrrolo £2, 1-c| £1, 4| benzodiazepine- 2-alkanoic acid derivatives having anti-allergic and anti-asthmatic activities, their preparation, and pharmaceutical compositions containing them |